MEngSc Biopharmaceutical Engineering

Graduate Taught (level 9 nfq, credits 90)

This Masters provides substantial coverage of scientific, technical, management and regulatory issues associated with this industry and offers an internationally recognised high quality flexible curriculum, which follows the latest developments in science and technology. This programme is suitable for Science and Engineering graduates wishing to obtain a qualification which is highly relevant to the biopharmaceutical industry.

Excellent employment record
This programme has an excellent employment record. This Masters results in an internationally recognised graduate qualification that provides graduates with the knowledge and skills required to gain high level professional jobs in the biopharmaceutical and pharmaceutical sector.

Facilities and Resources
This programme is closely linked with the NIBRT facility. NIBRT offers a quality training and research experience not previously possible anywhere in the world. At the heart of the NIBRT building is the bioprocessing pilot plant, consisting of extensive upstream, downstream, fill-finish and the associated analytical facilities. These facilities are all operated in a realistic GMP simulated, operational manufacturing environment.

Full Time option suitable for:

Domestic(EEA) applicants: Yes
International (Non EEA) applicants currently residing outside of the EEA Region. Yes

Part Time option suitable for:

Domestic(EEA) applicants: Yes
International (Non EEA) applicants currently residing outside of the EEA Region. No

The MEngSc Biopharmaceutical Engineering programme provides intensive training in the requisite skills for a professional engineer or scientist in the biopharmaceutical or related sector. The programme provides substantial coverage of the scientific, technical, management and regulatory issues associated with this industry.  The programme's teaching methods are highly interactive and varied and student learning is assessed using a variety of assessment methodology including exams, assignments, case studies and presentations.  Students complete a research project which consolidates their basic knowledge of the course content and provides intensive research experience and training. The course content addresses the principal scientific and engineering challenges involved in the design, operation and management of biopharmaceutical production facilities.  It is anticipated that graduates from this programme will play an important role in the development, design and operation of biopharmaceutical processes throughout the industry in the coming years.

  • Demonstrate an understanding of the scientific principles involved in the development of a biopharmaceutical production process
  • Understand the engineering principles underlying the production of biopharmaceuticals
  • Demonstrate an integrated knowledge of GMP and the regulatory issues involved in biopharmaceutical production
  • Apply their knowledge of biopharmaceutical production processes to design, equip and manage a biopharmaceutical production factility
  • Demonstrate the ability to work as part of a design team for the development of a new production facility
  • Demonstrate an understanding and appreciation of the challenges involved in the downstream purification of biopharmaceuticals
  • Demonstrate an understanding of the fundamentals of process control when applied to growth of mammalian cells in bioreactors
  • Demonstrate an appreciation of the concept and practice of independent research in specialised topics in biopharmaceutical engineering

Your career opportunities upon graduation from this programme are exemplary. Ireland is a world player in pharmaceutical and biopharmaceutical production.

The pharmaceutical industry in Ireland comprises a mix of international and local companies. Approximately, 120 overseas companies have plants in Ireland, including many of largest pharmaceutical and biopharmaceutical companies in the world including Pfizer, GSK, Merck, AbbVie, Novartis, Jansen Biologics (Ireland), Biomarin, Roche, Sanofi Genzyme and many more. Upon graduation from this programme, you will enjoy an extremely high job placement rate with superlative career opportunities.

MEngSc Biopharmaceutical Engineering (T015) Part Time
EU          Year 1 - € 3940
EU          Year 2 - € 3940
EU          Year 3 - € 1910

MEngSc Biopharmaceutical Engineering (T070) Full Time
EU          fee per year - € 7490
nonEU    fee per year - € 23800

***Fees are subject to change
Tuition fee information is available on the UCD Fees website. Please note that UCD offers a number of graduate scholarships for full-time, self-funding international students, holding an offer of a place on a UCD graduate degree programme. For further information please see International Scholarships.

  • An honours undergraduate degree (NFQ level 8) with a minimum upper second class honours  or international equivalence in a relevant Engineering, Science or Technology programme. However, all applicants will be assessed on a case-by-case basis and relevant or extensive work experience will be taken into account, so that in certain exceptional cases an award at a lower level or a 2.2 classification may be considered.
  • Applicants whose first language is not English must also demonstrate English language proficiency of IELTS 6.5 (no band less than 6.0 in each element), or equivalent.

Kate McCarthy, Amgen.

An Undergraduate Degree in Medicinal Chemistry meant I had a detailed knowledge of how drugs interact at a cellular level. I recognised that I wanted to know more about the Biopharmaceutical industry and this Masters course provided me with that knowledge; it bridged the gap between the science behind the drug and the manufacturing process. 

The modules I studied such as lean six sigma, regulatory affairs, GMP, facility design & bioseparations were a brilliant platform providing me with the means to obtain a manufacturing role within industry. Not only was the theory taught exceptionally well but also the practical training carried out in the NIBRT facility within the UCD Campus allowed for a means of putting theory into practice and gave a great insight into the processes carried out within a typical Biopharmaceutical plant. I would highly recommend this course to anyone looking to broaden their career opportunities as well as their understanding of the industry.

  • MEngSc Chemical Engineering
  • MSc Biotechnology

  • The following entry routes are available:

    MEngSc Biopharmaceutical Engineering FT (T070)
    Duration
    1 Years
    Attendance
    Full Time
    Deadline
    Closed
    MEngSc Biopharmaceutical Engineering PT (T015)
    Duration
    2 Years
    Attendance
    Part Time
    Deadline
    Closed

    * Courses will remain open until such time as all places have been filled, therefore early application is advised